Biggest short-interest movers, October 26, 2026: Liquidia leads the builds, Davide Campari-Milano tops Europe
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

US
Short sellers added most to Liquidia (LQDA): short interest rose 7.8 points in a session to 26.7% of free float, against a one-year high of 27.8%, and is up 8.0 points on the week, while the stock gained 28.2% over the week.
The largest cover was in Savara (SVRA), where short interest fell 11.5 points to 25.4%, while the stock lost 2.4% over the week.
Across the 2185 US stocks above $1B we track, short interest rose in 1174 and fell in 1008.
Biggest short-interest builds: US
| Company | Ticker | SI % free float | 1-day change | 1-week change | Days to cover | Cost to borrow |
|---|---|---|---|---|---|---|
| Liquidia Corporation | LQDA | 26.7% | +7.8 pts | +8.0 pts | 2.3 | 0.41% |
| Bob's Discount Furniture, Inc. | BOBS | 31.0% | +5.7 pts | +5.8 pts | 12.8 | 0.79% |
| Grindr Inc. | GRND | 20.4% | +5.3 pts | +7.0 pts | 4.7 | 0.59% |
| Talen Energy Corporation | TLN | 10.6% | +5.1 pts | +4.1 pts | 3.2 | 0.52% |
| MiniMed Group, Inc. | MMED | 6.9% | +5.1 pts | +5.0 pts | 1.1 | 3.38% |
| Cerebras Systems Inc. | CBRS | 20.1% | +4.9 pts | +4.6 pts | 2.0 | 0.54% |
| VNET Group, Inc. | VNET | 48.0% | +4.6 pts | +5.0 pts | 7.7 | 0.75% |
| Replimune Group, Inc. | REPL | 33.3% | +4.5 pts | +2.5 pts | 11.2 | 0.39% |
| EquipmentShare.com Inc. | EQPT | 15.6% | +4.5 pts | +3.9 pts | 4.9 | 0.75% |
| H2O America | HTO | 5.2% | +4.3 pts | +4.2 pts | 3.6 | 0.50% |
Biggest short-interest covers: US
| Company | Ticker | SI % free float | 1-day change | 1-week change | Days to cover | Cost to borrow |
|---|---|---|---|---|---|---|
| Savara Inc. | SVRA | 25.4% | -11.5 pts | -11.1 pts | 11.1 | 0.56% |
| Globant S.A. | GLOB | 21.0% | -8.8 pts | -9.9 pts | 8.9 | 0.59% |
| Pacira BioSciences, Inc. | PCRX | 9.9% | -8.6 pts | -8.9 pts | 1.5 | 0.49% |
| Ibotta, Inc. | IBTA | 37.3% | -7.5 pts | -7.9 pts | 10.4 | 0.92% |
| Xencor, Inc. | XNCR | 22.7% | -7.5 pts | -7.5 pts | 7.0 | 0.47% |
| Vera Therapeutics, Inc. | VERA | 26.0% | -6.6 pts | -6.6 pts | 7.6 | 0.40% |
| Fortrea Holdings Inc. | FTRE | 8.1% | -6.0 pts | -6.2 pts | 4.2 | 0.43% |
| NewAmsterdam Pharma Company N.V. | NAMS | 17.3% | -6.0 pts | -6.0 pts | 9.8 | 0.47% |
| Albertsons Companies, Inc. | ACI | 17.9% | -6.0 pts | -1.1 pts | 5.9 | 0.61% |
| Chewy, Inc. | CHWY | 81.0% | -5.6 pts | -8.8 pts | 3.6 | 0.40% |
Europe
Short sellers added most to Davide Campari-Milano (CPR): short interest rose 0.90 points in a session to 11.1% of free float, against a one-year high of 19.1%, and is up 3.3 points on the week.
The largest cover was in Bonesupport (BONEX), where short interest fell 1.5 points to 6.6%, while the stock gained 35.4% over the week.
Across the 1060 European stocks above $1B we track, short interest rose in 326 and fell in 353.
CPR, SCATC and LEG were also among the biggest builds in the previous edition.
Biggest short-interest builds: Europe
| Company | Ticker | SI % free float | 1-day change | 1-week change | Days to cover | Cost to borrow |
|---|---|---|---|---|---|---|
| Davide Campari-Milano N.V. | CPR | 11.1% | +0.90 pts | +3.3 pts | 11.8 | 1.09% |
| Scatec ASA | SCATC | 6.7% | +0.76 pts | +1.6 pts | 9.6 | 0.73% |
| LEG Immobilien SE | LEG | 6.5% | +0.63 pts | +4.4 pts | 7.3 | 1.17% |
| Stellantis N.V. | STLAM | 12.1% | +0.62 pts | +1.4 pts | 6.5 | 1.04% |
| Gaztransport & Technigaz SA | GTT | 3.5% | +0.51 pts | +0.52 pts | 9.6 | 0.65% |
| Solaria Energía y Medio Ambiente, S.A. | SLR | 9.8% | +0.49 pts | -0.20 pts | 7.1 | 0.75% |
| Nanobiotix S.A. | NANO | 2.5% | +0.45 pts | +0.67 pts | 4.6 | 8.62% |
| Lifco AB (publ) | LIFCO B | 6.4% | +0.44 pts | +0.56 pts | 25.3 | 0.85% |
| CSG N.V. | CSG | 5.5% | +0.43 pts | +0.48 pts | 11.2 | 1.34% |
| Okeanis Eco Tankers Corp. | OET | 1.9% | +0.42 pts | -2.5 pts | 4.1 | 1.75% |
Biggest short-interest covers: Europe
| Company | Ticker | SI % free float | 1-day change | 1-week change | Days to cover | Cost to borrow |
|---|---|---|---|---|---|---|
| Bonesupport Holding AB (publ) | BONEX | 6.6% | -1.5 pts | -4.5 pts | 7.7 | 0.99% |
| Siltronic AG | WAF | 4.1% | -1.2 pts | -2.4 pts | 4.9 | 1.67% |
| Renault SA | RNO | 20.2% | -0.91 pts | -0.42 pts | 18.8 | 0.81% |
| Mota-Engil, SGPS, S.A. | EGL | 7.9% | -0.75 pts | -0.62 pts | 5.0 | 16.55% |
| AAK AB (publ.) | AAK | 11.6% | -0.62 pts | -0.72 pts | 32.2 | 1.02% |
| TeamViewer SE | TMV | 3.9% | -0.47 pts | -0.67 pts | 9.1 | 0.71% |
| Wolters Kluwer N.V. | WKL | 0.1% | -0.43 pts | -0.06 pts | 0.2 | 0.52% |
| J D Wetherspoon plc | JDW | 6.6% | -0.39 pts | -2.1 pts | 11.4 | 1.25% |
| NKT A/S | NKT | 9.6% | -0.37 pts | -1.6 pts | 30.0 | 0.75% |
| Crédit Agricole S.A. | ACA | 1.2% | -0.37 pts | -1.4 pts | 1.8 | 1.17% |
Stocks in this article
- LQDALQDA data on ORTEX
- SVRASVRA data on ORTEX
- BOBSBOBS data on ORTEX
- GRNDGRND data on ORTEX
- TLNTLN data on ORTEX
- MMEDMMED data on ORTEX
- CBRSCBRS data on ORTEX
- VNETVNET data on ORTEX
- REPLREPL data on ORTEX
- EQPTEQPT data on ORTEX
- HTOHTO data on ORTEX
- GLOBGLOB data on ORTEX
- PCRXPCRX data on ORTEX
- IBTAIBTA data on ORTEX
- XNCRXNCR data on ORTEX
- VERAVERA data on ORTEX
- FTREFTRE data on ORTEX
- NAMSNAMS data on ORTEX
- ACIACI data on ORTEX
- CHWYCHWY data on ORTEX
- CPRCPR data on ORTEX
- BONEXBONEX data on ORTEX
- SCATCSCATC data on ORTEX
- LEGLEG data on ORTEX
- STLAMSTLAM data on ORTEX
- GTTGTT data on ORTEX
- SLRSLR data on ORTEX
- NANONANO data on ORTEX
- CSGCSG data on ORTEX
- OETOET data on ORTEX
- WAFWAF data on ORTEX
- RNORNO data on ORTEX
- EGLEGL data on ORTEX
- AAKAAK data on ORTEX
- TMVTMV data on ORTEX
- WKLWKL data on ORTEX
- JDWJDW data on ORTEX
- NKTNKT data on ORTEX
- ACAACA data on ORTEX
How this article was generated
- Generated
- 27 Oct 2026, 12:36
- Data as of
- 26 Oct 2026, 00:00
- Prompt version
- roundup-v1
- Data sources
- Short interestCost to borrow
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.